Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
Holding KZR?
Track your performance easily

Kezar Life Sciences (KZR) Financial Statements

467 Followers

Kezar Life Sciences Financial Overview

Kezar Life Sciences's market cap is currently ―. The company's EPS TTM is $-13.546; its P/E ratio is -0.55; Kezar Life Sciences is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue---$ 7.00M-
Gross Profit---$ 7.00M-
EBIT$ -21.15M$ -21.26M$ -31.86M$ -22.71M$ -23.92M
EBITDA$ -19.31M$ -21.00M$ -31.58M$ -22.43M$ -21.90M
Net Income Common Stockholders$ -21.55M$ -21.66M$ -32.26M$ -23.10M$ -24.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 164.18M$ 179.80M$ 201.37M$ 218.21M$ 236.59M
Total Assets$ 179.92M$ 199.13M$ 221.24M$ 249.33M$ 263.38M
Total Debt$ 17.61M$ 18.29M$ 18.93M$ 19.55M$ 20.15M
Net Debt$ -146.57M$ -161.51M$ -182.44M$ -198.65M$ -216.44M
Total Liabilities$ 29.24M$ 30.01M$ 33.66M$ 33.33M$ 31.10M
Stockholders Equity$ 150.69M$ 169.14M$ 187.57M$ 215.99M$ 232.28M
Cash Flow-
Free Cash Flow$ -17.03M$ -22.86M$ -18.98M$ -20.34M$ -22.98M
Operating Cash Flow$ -17.03M$ -22.86M$ -18.98M$ -20.20M$ -21.60M
Investing Cash Flow$ 12.22M$ 20.41M$ 27.88M$ 18.57M$ 13.20M
Financing Cash Flow$ 56.00K-$ 59.00K$ 43.00K$ 382.00K
Currency in USD

Kezar Life Sciences Earnings and Revenue History

Kezar Life Sciences Debt to Assets

Kezar Life Sciences Cash Flow

Kezar Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis